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Abstract
Amyloidosis describes a group of protein folding diseases in which amyloid proteins are abnormally deposited in organs
and/or tissues as fine fibrils. Mouse senile amyloidosis is a disorder in which apolipoprotein A-II (apoA-II) deposits as amyloid
fibrils (AApoAII) and can be transmitted from one animal to another both by the feces and milk excreted by mice with
amyloidosis. Thus, mouse AApoAII amyloidosis has been demonstrated to be a ‘‘transmissible disease’’. In this study, to
further characterize the transmissibility of amyloidosis, AApoAII amyloid fibrils were injected into transgenic Apoa2
cTg
+/2
and normal R1.P1-Apoa2
c mice to induce AApoAII systemic amyloidosis. Two months later, AApoAII amyloid deposits were
found in the skeletal muscles of amyloid-affected mice, primarily in the blood vessels and in the interstitial tissues
surrounding muscle fibers. When amyloid fibrils extracted from the skeletal muscles were subjected to Western blot
analysis, apoA-II was detected. Amyloid fibril fractions isolated from the muscles not only demonstrated the structure of
amyloid fibrils but could also induce amyloidosis in young mice depending on its fibril conformation. These findings present
a possible pathogenesis of amyloidosis: transmission of amyloid fibril conformation through muscle, and shed new light on
the etiology involved in amyloid disorders.
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Introduction
Amyloidosis refers to a group of protein folding disorders.
Various proteins that are harmless and soluble under normal
physiological conditions can undergo marked conformational
changes and subsequent self-assembly outside of the cell into
highly stable, insoluble amyloid fibrils with a high content of ß-
sheet structures. Currently, twenty-eight different kinds of human
proteins, in intact or fragmented forms, have been found to be
amyloidogenic in vivo and to be associated with pathological
disorders such as prion diseases, Alzheimer’s disease, type II
diabetes, dialysis-related amyloidosis, and familial, systemic, and
sporadic amyloidosis [1,2].
Many factors, such as aging and epigenetic factors, including
lifestyle and types of food ingested, may influence fibril formation
and deposition in organs and/or tissues. Transmission of amyloid
fibrils might act as an important etiological factor of amyloidosis.
Exogenous amyloid fibrils could act as a seed (nuclei) and change
the conformation of endogenous amyloid protein into that of
fibrils, such as PrP
Sc, reactive (AA) and AApoAII amyloid fibrils
[3,4,5]. Transmissible spongiform encephalopathies (TSEs) com-
prise a group of infectious neurodegenerative diseases that affect
humans and other animals and are characterized by accumulation
of the misfolded, protease-resistant prion protein PrP
Sc in the
central nervous system [6,7]. It is hypothesized that TSEs are
transmitted from one species to another through ingestion of
urine, saliva, and/or infected meat [7].
Apolipoprotein A-II (apoA-II) is present in the plasma of
humans, mice, rats, and fish [8,9]. In mice, apoA-II is the second
most abundant apoprotein in serum high density lipoprotein
(HDL), and accumulates to form amyloid fibrils (AApoAII) in
many organs, leading to senile amyloidosis [10]. In laboratory
mice, three major alleles (Apoa2
a, Apoa2
b and Apoa2
c) of the apoA-II
gene encode three variants of the apoA-II protein [11,12]. Several
genetic analyses have indicated that the Apoa2
c allele markedly
accelerates age-associated deposition of AApoAII [13]. Mouse
AApoAII amyloidosis has been demonstrated to be a transmissible
disease by a prion-like infectious process occurring through a
seeding-nucleation mechanism [4,14]. Our group found that a
single intravenous injection of a very small amount of AApoAII
amyloid fibrils (,10
213g) led to systemic deposition of amyloid in
young mice [15,16]. AApoAII amyloidosis can also be transmitted
by the feces [17] and milk [18] excreted by mice with AApoAII
amyloidosis. Furthermore, transmission of AApoAII amyloidosis
shows a ‘strain phenomenon’ analogous to the prion strains [10].
Thus, the fibrillar nuclei or amyloid fibrils formed by the
aggregation of misfolded protein monomers (rich in ß-sheet
structures) act as seeds to induce and stabilize conversion of the
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plausible explanation for the transmissible nature of AApoAII
amyloidosis.
In the present study, we found AApoAII amyloid fibrils in the
skeletal muscles of AApoAII amyloid-affected mice. Unexpectedly,
amyloid fibrils isolated from the muscles were demonstrated to be
sufficient for the transmission of amyloidosis. These findings
provide important implications for assessing the potential risk of
consuming amyloid-deposited skeletal muscles in the transmission
of amyloidosis.
Results
Expression of apoA-II mRNA in muscle tissue
To confirm whether apoA-II mRNA is expressed in mouse
skeletal muscle, total RNA was extracted from the triceps brachii
muscles in the forelimbs, the femoral quadriceps muscles in the
hindlimb, the longissimus thoracis muscle in the back and the
greater pectoral muscles from the breast of Apoa2
cTg
+/2 mice and
R1.P1-Apoa2
c mice. ApoA-II mRNAs were detected in several
muscles obtained from these mice. Interestingly, expression levels
in muscle tissues were lower than those seen in liver (Figure 1A).
Quantitative real time PCR analysis revealed that the expression
levels of apoA-II mRNA in the muscles were about one tenth and
one thirtieth of the expression levels observed in the livers from
Apoa2
cTg
+/2 and R1.P1-Apoa2
c mice, respectively, and expression
levels were significantly higher in Apoa2
cTg
+/2 mice (Figure 1B).
AApoAII amyloid deposits in the muscle
To determine whether amyloid fibrils exist in the muscles of
AApoAII-deposited mice, we intravenously injected 1 mgo f
isolated AApoAII fibrils into six 2-month-old female Apoa2
cTg
+/2
mice. Two months later, amyloid deposition was detected by the
presence of green birefringence in Congo Red-stained tissue from
four muscles of Apoa2
cTg
+/2 mice displaying heavy amyloid
deposits throughout the body. Histological examination revealed
that muscles of all Apoa2
cTg
+/2 were deposited with amyloid (6/
6; Table 1). In amyloid fibril-injected normal R1.P1-Apoa2
c mice,
obvious amyloid deposition was observed only in one of three
mice at two months after injection (1/3), and all three had
amyloid deposits at four months after injection (3/3); that is, in
skeletal muscles, the deposition of AApoAII amyloidosis increased
with age. Amyloid deposits were found mainly in the blood
vessels of muscle tissues, but were also found in connective tissues
around muscle fibers (endomysium) both in Apoa2
cTg
+/2 mice
(Figure 2A, B) and R1.P1-Apoa2
c mice (Figure 2E, F). AApoAII
amyloid deposition, which was observed in muscles, was further
confirmed with anti-apoA-II staining (Figure 2C, D, G, and H).
However, no deposits of AApoAII amyloid fibrils were found in
Figure 1. Expression of apoA-II mRNA in various skeletal
muscles. A. Expression of apoA-II mRNA was determined by RT-PCR
analysis with 23 cycles from four different muscles in Apoa2
cTg
+/2 and
R1.P1-Apoa2
c mice. Lane 1, forelimb triceps brachii muscles. Lane 2,
hindlimb femoral quadriceps muscles. Lane 3, longissimus thoracis
muscles from the back. Lane 4, greater pectoral muscles from the
breast. Lane 5, liver as a control. B. Real-time PCR analysis of apoA-II
mRNA levels in the greater pectoral muscle and the liver of the
Apoa2
cTg
+/2 and R1.P1-Apoa2
c mice (
**p,0.01).
doi:10.1371/journal.ppat.1000914.g001
Author Summary
‘‘Amyloidosis’’, a group of protein folding diseases
characterized by deposition of fine fibrils in tissues, is a
common disorder of protein metabolism and can be
acquired, inherited and/or age-associated. Recently, prion-
like transmission has been found in various amyloidoses.
AApoAII amyloid fibrils in mouse senile amyloidosis have
exhibited transmissibility. For instance, ingested AApoAII
amyloid fibrils, which were excreted from mice and
contained in feces or milk, function as seeds for changing
apoA-II amyloid precursor protein to the fibrillar form and
cause mouse senile amyloidosis. However, transmissibility
through other pathways has not yet been established.
Here, we induced AApoAII systemic amyloidosis in
transgenic Apoa2
cTg
+/2 and normal R1.P1-Apoa2
c mice
to analyze the transmissibility of mouse senile amyloidosis
through muscle tissues. In this study, we not only detected
AApoAII deposited in various skeletal muscles, but also
found that it could induce secondary transmission of
AApoAII amyloidosis. This is the first evidence of transmis-
sion through skeletal muscles in non-prion systemic
amyloidosis. This pathway of transmission provides new
insight into the potential for food-borne pathogenesis and
etiology of systemic amyloidosis.
Table 1. Deposition of AApoAII amyloid fibrils in the muscles
of Apoa2
cTg
+/2 and R1.P1-Apoa2
c mice.
Mouse strain
Injected
fibrils (mg)
Time after
injection
with AApoAII
fibrils (months)
Rate of amyloid
deposition
in the muscles
(positive/total)*
Apoa2
cTg
+/2 1 2 6/6
R1.P1-Apoa2
c 100 2 1/3
R1.P1-Apoa2
c 100 4 3/3
R1.P1-Apoa2
c 0 2 0/3
AApoAII deposition was determined by staining with Congo red or anti-apoA-II
antiserum in tissue sections taken from four muscles from each mouse.
*number of mice with amyloid deposition in any of the four muscles.
doi:10.1371/journal.ppat.1000914.t001
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c mice (0/3) without induction
by AApoAII fibrils.
Amyloid fibril fractions were isolated from various muscles
and apoA-II protein was detected by Western blot analysis.
ApoA-II proteins were detected in amyloid fibril fractions of
femoral quadriceps muscles in the hindlimb of Apoa2
cTg
+/2
mice with AApoAII-deposition but similar results were not
observed in the muscles of R1.P1-Apoa2
c control mice lacking
AApoAII-deposition (Figure 3A). Moreover, apoA-II was also
detected in all four kinds of muscle of Apoa2
cTg
+/2 mice
(Figure 3B). In R1.P1-Apoa2
c mice, two months after injection of
amyloid fibrils, apoA-II was detected in greater pectoral muscles
in the breast of all three mice. Four months after injection,
apoA-II deposition expanded to other muscles and amounts of
apoA-II increased (Figure 3C). The amount of deposition was
different among different muscles: greater pectoral muscles from
the breast . longissimus thoracis muscle in the back . triceps
brachii muscles in the fore-limbs . femoral quadriceps muscles
in the pelvic-limb.
Detection of amyloid fibrils in muscle by transmission
electron microscopy
To further confirm the existence of amyloid fibrils in muscle
tissues, the amyloid fibril fractions of muscle tissues from the
AApoAII-deposited Apoa2
cTg
+/2 mice and R1.P1-Apoa2
c mice
without AApoAII-deposition were observed by transmission
electron microscopy. We found amyloid fibrils extracted from
Figure 2. Amyloid deposition in the muscle. Amyloid deposits in
the breast greater pectoral muscles from the 4-month-old Apoa2
cTg
+/2
mice two months after injection with AApoAII amyloid fibrils (A, B, C
and D) and from 6-month-old R1.P1-Apoa2
c mice with 4-month AApoAII
amyloid induction (E, F, G and H). Amyloid depositions in the blood
vessels (A and E) and interstitial tissues surrounding muscle fibrils (B
and F) in the pectoral muscles manifest as green birefringence in Congo
red-stained sections. Deposition of amyloid was identified with anti-
apoA-II antiserum (C, D, G and H). The arrows indicate amyloid
deposition in the muscle. Magnification=6400.
doi:10.1371/journal.ppat.1000914.g002
Figure 3. ApoA-II protein detected in amyloid fibril fractions
isolated from various muscles. A. ApoA-II protein in amyloid fibril
fractions of the hindlimb muscles from six Apoa2
cTg
+/2 mice injected
with AApoAII (mouse-1 to mouse-6 in lane 1 to 6), and three R1.P1-
Apoa2
c mice without AApoAII injection (mouse-1 to mouse-3 in lane 7
to 9) were detected with anti-mouse apoA-II antiserum. 25 mgo f
protein were loaded into each lane. B. ApoA-II protein found in various
muscles of Apoa2
cTg
+/2 mouse-1 injected with AApoAII (Lane 1 to 4)
and a non-injected R1.P1-Apoa2
c mouse-1 (lane 5 to 8). Lane 1 and 5:
forelimb triceps brachii muscles. Lane 2 and 6: hindlimb femoral
quadriceps. Lane 3 and 7: longissimus thoracis muscles in the back.
Lane 4 and 8: greater pectoral muscles from the breast. C. ApoA-II
protein found in various muscles of R1.P1-Apoa2
c mice (two or four
months after injection with AApoAII fibrils). Lane 1, 5, 9, 13, 17 and 21;
forelimb triceps brachii muscles. Lane 2, 6, 10, 14, 18 and 22: hindlimb
femoral quadriceps muscles. Lane 3, 7, 11, 15, 19 and 23: longissimus
thoracis muscles in the back. Lane 4, 8, 12, 16, 20 and 24: greater
pectoral muscles.
doi:10.1371/journal.ppat.1000914.g003
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(Figure 4A), but not in the fractions of mice without deposition.
Ultrastructural analysis of cross sections of AApoAII-deposited
muscle was performed by transmission electron microscopy.
Bundles of amyloid fibrils deposited in endomysiums and capillary
walls of skeletal muscles were observed (Figure 4B and C).
Induction of amyloidosis with amyloid fibril fractions
isolated from AApoAII-deposited muscles
To elucidate whether AApoAII amyloid transmissibility existed in
skeletal muscle, amyloid fibril fractions were isolated from femoral
quadriceps muscles of Apoa2
cTg
+/2 mice with AApoAII deposition
(Figure 5) and were injected into 2-month-old female R1.P1-Apoa2
c
mice. Two months following injection, amyloid deposits were
observed in the tongue (6/6), lungs (6/6), stomach (6/6), heart
(6/6),intestine(4/6),andskin(1/6)ofsixinjectedmice(Table2).The
mean AI was 1.19. In contrast, significantly less amyloid deposition
was observed when the mice were injected with fractions isolated
from R1.P1-Apoa2
c mice without AApoAII-deposition; the mean AI
was 0.26 (p=0.0062). Additionally, we found that injection of fibril
fractions extracted from no AApoAII deposited muscles from R1.P1-
Apoa2
c mice induced a small amount of amyloid deposition (2/5 mice
had AApoAII deposits and mean AI=0.10). To confirm this,
amyloid fibril fractions were extracted from muscles of young (2-
month-old) female R1.P1-Apoa2
c mice. Although these fractions
induced secondary transmission in mice, neither apoA-II nor AA
could be detected in the fraction by Western blot analysis (Figure 5).
Unexpectedly, slight amyloid depositions were observed inthe tongue
(5/7) and stomach (3/7) of seven injected mice two months after
injection; mean AI=0.20.
Figure 4. Transmission electron microscopy images of amyloid fibrils deposited in muscles. A. Amyloid fibrils extracted from the muscles
of an AApoAII-deposited Apoa2
cTg
+/2 mouse corresponding to lane 1 in Figure 3A. Transmission of electron micrographs of pectoral muscles from
the 4-month-old Apoa2
cTg
+/2 mice two months after injection and confirmed fibrillar deposits in the endomysium (4B) and capillary walls (4C).
Arrowheads indicate the amyloid deposits. The highmagnification insets of the areas surrounded with white squares shows the fibrillar nature of the
deposits. Scale bar=0.2 mm.
doi:10.1371/journal.ppat.1000914.g004
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AApoAII amyloidosis
Amyloid fractions denatured by guanidine hydrochloride were
injected into six 2-month-old female R1.P1-Apoa2
c mice. No
amyloid deposition was detected in any of these mice two months
later (0/6) (Table 2).
Discussion
Our previous work in senescence-accelerated mice determined
that AApoAII amyloid fibrils are deposited throughout the body,
including in the liver, spleen, stomach, intestine, heart, kidneys,
lungs, tongue, skin, gonads, adrenal glands, salivary and thyroid
glands, thymus, mesenteric lymph nodes, epineurium of the sciatic
nerve and blood vessels in various tissues; however, no evidence of
amyloid deposition was found in brain parenchyma or bone
marrow in the vertebral body of the lumbar spine [21]. Although
amyloid fibrils were also detected in the musculoskeletal systems,
there were no detailed descriptions nor further studies on
AApoAII amyloid deposition in the skeletal muscles [21].
The current study demonstrates that skeletal muscle tissue is
capable of propagating AApoAII amyloidosis in mice. We first
detected AApoAII amyloid fibrils in four skeletal muscles in
different body regions using immunohistochemistry, Western blot
analysis and electron microscopy. Amyloid deposits were observed
in blood vessels and interstitial tissues surrounding muscle fibers.
However, no AApoAII was observed in muscle cells or in the
nerve fibers in which prion proteins were previously detected [22].
Although apoA-II mRNA was detected in muscle tissues (Figure 1),
it is unclear whether apoA-II protein in AApoAII fibrils around
muscle fibers originates from muscle cells or blood. Interestingly,
the amounts of amyloid deposition in the skeletal muscles differed
among body regions; that is, breast . back . forelimb .
hindlimb. This order is different from that observed in mice
inoculated with prion protein [23]. First, we observed amyloid
deposition in Apoa2
cTg
+/2 mice in which apoA-II protein is
overexpressed in various tissues under the control of a ubiquitous
promoter, and found that serum levels of apoA-II increased the
susceptibility to induction of AApoAII [24]. As a result, AApoAII
deposits in muscles were found in Apoa2
cTg
+/2 mice. Second, we
also observed AApoAII deposits in the muscles of R1.P1-Apoa2
c
mice in which apoA-II was expressed under an endogenous
promoter/enhancer. According to the above results, it was found
that AApoAII is deposited in the skeletal muscles as part of a
universal phenomenon. Next, we demonstrated that intravenous
injection of amyloid fibrils extracted from muscle tissues could
transmit amyloidosis depending on fibril-conformation. That is,
transmissibility was lost following denaturation with 6 mol/L
guanidine hydrochloride. In previous studies, AApoAII amyloid
fibril was extremely efficient in inducing amyloidosis following
doses of less than 1 pg; moreover, amyloidosis could be initiated
after oral ingestion of AApoAII fibrils [16,17,25]. Thus, the
infectious ability of skeletal muscle raised the possibility that mouse
AApoAII amyloidosis may result, in part, from dietary exposure to
amyloid fibrils through consumption of muscle/meat containing
amyloid materials.
Animal muscles, an important food component for most
humans, have been examined in several studies for the presence
of TSE transmissibility [23,26]. Recently, it was reported that high
prion titers and the disease-causing isoform of the prion protein
PrP
Sc appear in the skeletal muscles of mice, hamsters and sheep
inoculated with prion agents [27,28,29,30], and in deer infected
with chronic wasting disease [31]. Furthermore, PrP
Sc is also
present in skeletal muscle samples of sporadic Creutzfeldt-Jacob
disease (CJD) in humans [32], and has been demonstrated to be
present in the nerve fibers of skeletal muscles tissue [23]. Although
some findings are contradictory to the above reports [33],
elucidation of the contribution of muscle tissues to transmission
is important for the prevention of prion-related disorders. Prion-
like transmission has been reported in mouse inflammation-
associated amyloid A (AA) amyloidosis [34]. Dietary supply of
amyloid fibrils might also be a trigger in the development of AA
amyloidosis, especially for a susceptible population. Notably, it was
reported that 71.4% of skeletal muscles from cows with systemic
AA amyloidosis stained positive with anti-AA antibody [35].
Although an unexpectedly high incidence of visceral AA-
amyloidosis in aged slaughtered cattle in Japan was reported,
and isolated AA amyloid fibrils exhibited amyloid-enhancing
factor activity, amyloid deposition in the skeletal muscles was rare
[36,37].
Thus, these studies support the idea of the transmissibility of
systemic AApoAII and AA amyloidosis from skeletal muscle.
Additionally, we found that injection of fibril fractions extracted
from either control non-AApoAII injected or, no AApoAII
deposited muscles of young R1.P1-Apoa2
c mice induced a small
amount of amyloid deposition, although these fractions contained
neither apoA-II nor AA detectable by Western blot analysis. It is
possible that extracts contain trace amounts of AApoAII amyloid
fibrils or oligomers that could not be detected by available
techniques and these undetectable AApoAII peptides might be
transmissible like PrP
res [38]. Alternatively, components other
than AApoAII amyloid fibrils might induce amyloid deposition. In
R1.P1-Apoa2
c mice, AApoAII amyloid can be seeded by various
heterogeneous amyloid fibrils (cross-seeding) [39] and unexpect-
Figure 5. Western blot analysis of amyloid fibril fractions
extracted from muscles used for secondary transmission. Lane
1, Amyloid fibril fractions (2.5 mg) isolated from femoral quadriceps
muscles of Apoa2
cTg
+/2 mice with AApoAII deposition. Lane 2,
Denatured muscle amyloid fibril fraction (2.5 mg) from Apoa2
cTg
+/2
mice. Lane 3, Muscle amyloid fibril fraction extracted (5.0 mg) from
R1.P1-Apoa2
c mice without amyloid injection. Lane 4, Amyloid fibril
fraction from liver (1 mg) used as a control. ApoA-II was detected with
anti-apoA-II antiserum.
doi:10.1371/journal.ppat.1000914.g005
Table 2. AApoAII amyloid deposits in R1.P1-Apoa2
c mice
injected with amyloid fibril fractions isolated from the muscles
of AApoAII-deposited mice.
Injected fractions source
Positive/
total AI p-value
Muscle of Apoa2
cTg
+/2 (with amyloid
deposition)
6/6 1.19
a p,0.01
(a vs b)
Muscle R1.P1-Apoa2
c (without amyloid
injection)
4/5 0.26
b
Denatured amyloid fibril fraction
(muscle of Apoa2
cTg
+/2)
0/6 0
c p,0.01
(a vs c)
Amyloid fibril fractions were isolated from femoral quadriceps muscles of
Apoa2
cTg
+/2 mice with AApoAII deposition and were injected intravenously
into 2-month-old female R1.P1-Apoa2
c mice. After two months, mice were
sacrificed and amyloid deposition and AI were determined.
doi:10.1371/journal.ppat.1000914.t002
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fibril-like structures [40,41]. For example, collagen fibrils and
glycosaminoglycans, supportive structures in skeletal muscle,
appear to be actively involved in the induction of ß2-microglobulin
amyloid fibril formation [42].
Elevated levels of prion protein in muscle lead to myopathy and
neurogenic muscle atrophy in affected patients [43,44,45].
Accumulated amyloid proteins have been found in inclusion-body
myositis and are toxic to skeletal myoblasts [46]. Although we
observed amyloid deposits around skeletal muscle fibers after
inducing amyloidosis, further studies will be necessary to examine
possible myopathy and/or toxicity of these deposits.
In summary, apoA-II, which is present in the plasma of humans,
mice, rats, and fish [6,7], has been demonstrated in the form of
amyloid fibrils with transmissibility in mouse muscle. AApoAII
amyloid fibrils were detected in various skeletal muscles, especially
in the pectoral muscles. The verification of this transmission
pathway is valuable for understanding the pathogenesis and
etiology of amyloidosis.
Materials and Methods
Ethics statement
All experimental procedures were pre-approved by Division of
Laboratory Animal Research of Shinshu University and were
performed according to the guidelines of Division of Laboratory
Animal Research of Shinshu University.
Experimental procedures
R1.P1-Apoa2
c is a congenic strain of mice with the amyloidogenic
Apoa2
c allele from the SAMP1 strain in the genetic background of
SAMR1 [13]. Apoa2
c transgenic mice (Apoa2
cTg
+/2) were established
in the genetic background of R1.P1-Apoa2
c [24]. These strains were
maintained by sister-brother mating in the Division of Laboratory
Animal Research, Research Center for Human and Environmental
Science, Shinshu University. Mice were raised under specific
pathogen-free (SPF) conditions at 2462uC with a light-controlled
regimen (12-hour light/dark cycle). A commercial diet (MF; Oriental
Yeast, Tokyo, Japan) and tap water were provided ad libitum.I nt h i s
study, only female mice were used to avoid AA amyloidosis and/or
other adverse impacts caused by fighting or other behaviors among
mice reared in the same cage. All experiment procedures were
carried out in accordance with the Regulations for Animal
Experimentation of Shinshu University.
Detection of apoA-II mRNA expression in skeletal muscle
Total RNAs were extracted from the skeletal muscles and liver
(as control) using RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. First-strand cDNA
was synthesized from 1 mg total RNA of each muscle tissue (First-
strand cDNA Synthesis Kit; Amersham Pharmacia Biotech,
Piscataway, NJ) and subjected to PCR amplification with Taq
DNA polymerase (Promega; Madison, WI). The reverse tran-
scriptase-polymerase chain reaction (RT-PCR) amplification was
carried out in a 50-ml reaction mixture containing 200 mM each
dNTP, 16 buffer containing 1.5 mM MgCl2, 0.1 mM each
primer, and 1.25 U of Taq DNA polymerase. The cycling
parameters for RT-PCR were initial denaturation for 1 minute
at 94uC followed by 23 cycles of 30 sec at 94uC, 30 sec at 55uC,
and 1 min at 72uC. A 5-ml aliquot of the PCR product was
subjected to 3% agarose (Takara Bio, Otsu, Japan) gel
electrophoresis. SYBR Premix Ex Taq II (Takara Bio) was used
as the fluorescent marker to monitor DNA accumulation in
quantitative real time PCR analysis with the 7500 Real-Time PCR
System (Applied Biosystems Life Technologies, Tokyo Japan). The
primers used for PCR amplification of apoA-II mRNA were as
follows: A2/acc-F (59-AAGAGACAGGCGGACGGACA-39) and
A2/acc-R (59-GAGGTCTTGGCCTTCTCCAC-39).
Induction of AApoAII amyloidosis and preparation of
animal tissue samples
The AApoAII amyloid fibril fraction was isolated as a water
suspension from the livers of a 20-month-old R1.P1-Apoa2
c mouse
as described previously [10]. Purified amyloid fibrils were re-
suspended at a concentration of 1.0 mg/ml in distilled water
(DW). One milliliter of this solution was put into an Eppendorf
tube and sonicated on ice for 30 sec with an ultrasonic
homogenizer VP-5S (Tietech Co., Ltd., Tokyo, Japan) at power
level 4. This procedure was repeated five times at 30 sec intervals.
Sonicated amyloid samples were then immediately injected into
the caudal vein of mice to induce AApoAII amyloidosis.
Six 2-month-old female Apoa2
cTg
+/2 mice were injected intrave-
nously with 1 mg of AApoAII fibrils to induce AApoAII amyloidosis.
Two months later the mice were sacrificed and the triceps brachii
muscles in the forelimbs, the femoral quadriceps muscles in the
hindlimb, the longissimus thoracis muscles in the back, and the
greater pectoral muscles from the breast were dissected. Half of the
tissue was kept at 280uC and the other half was fixed in 10% neutral
buffered formalin, embedded in paraffin, and cut into 4-mms e c t i o n s .
Six 2-month-old female R1.P1-Apoa2
c mice were injected intrave-
nously with 100 mg of AApoAII fibrils; three were sacrificed after two
months and the other three were sacrificed after four months. Muscle
tissue was dissected and either stored or fixed and embedded in the
same fashion as the Apoa2
cTg
+/2 transgenic mice. Three female
R1.P1-Apoa2
c littermates not injected with fibrils, were sacrificed at
t w om o n t h sa sc o n t r o l s .
Isolation of AApoAII amyloid fibrils from muscle
AApoAII amyloid fibril fractions were isolated from the muscle
of amyloid fibril-injected mice by Pras’ method [47]. Thawed
muscles (0.1 g) were sonicated twice for 30 sec with a 30-second
rest interval in 1.0 ml of 0.15 M NaCl on ice using an ultrasonic
homogenizer VP-5S (Tietech Co., LTD, Tokyo, Japan) at power
level 4. The homogenate was centrifuged at 40,0006g for 20 min
at 4.0uC, after which the supernatant was discarded and the pellet
was re-suspended in 1.0 ml 0.15 M NaCl. The sonication and
centrifugation were repeated two more times, and the pellet was
suspended in 1.0 ml deionized DW (DDW) and centrifuged after
sonication once more. The pellet was re-suspended with DDW
and sonicated. Following centrifugation at 30,0006g for 20 min at
4.0uC, the supernatant containing amyloid fibrils was collected
and used for Western blotting, transmission electron microscopy
analysis and for the secondary transmission experiment.
Detection of AApoAII fibrils in the muscles by histology
and immunohistochemistry
Deposition of amyloid fibrils was identified by the appearance of
green birefringence in Congo Red-stained sections [48] visualized
under polarizing microscopy. AApoAII amyloid fibril proteins
were identified immunohistochemically using the avidin-biotiny-
lated horseradish peroxidase complex method with specific
antiserum against mouse apoA-II (1:3000) [49].
Detection of AApoAII fibrils in muscle by Western blot
examinations
Isolated amyloid fibril fractions (25 mg) from the muscles were
separated on Tris-Tricine sodium dodecyl sulfate-polyacrylamide
Senile Amyloidosis, Skeletal Muscle
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Proteins on the gel were electrophoretically transferred to
Immuno-Blot polyvinylidene difluoride membrane (0.2 mm pore
size; Bio-Rad, Hercules, CA, USA). Proteins on the membrane
were detected with rabbit anti-mouse apoA-II antiserum (1:3000),
followed by peroxidase-conjugated goat IgG against rabbit
immunoglobulin (1:1000; ICN Pharmaceuticals, Inc., Aurora,
OH, USA). Immunoreactive proteins were visualized with ECL
reagents (Amersham Biosciences, Buckinghamshire, England).
The film (Amersham Biosciences, Buckinghamshire, England)
was exposed for 3 min.
Detection of AApoAII fibrils in muscle tissue by
transmission electron microscopy
Aliquots (20 ml; 0.5 mg/ml) of amyloid fibril fractions isolated
from the muscles were applied to 400-mesh collodion-coated
copper grid (Nissin EM Co., Ltd., Tokyo, Japan) for 1 min and
subjected to negative staining with 1% phosphotungstic acid
(pH 7.0) for 1 min. The negatively stained samples were observed
with a JEOL 1200 EX electron microscope (JEOL, Tokyo, Japan)
operated at 80 kV. Electron micrographs were taken with a Gatan
multiscan camera model 791 with Gatan digital micrograph
software version 3.6.4 (Gatan, Pleasanton, CA, USA). For
ultrastructural analysis by electron microscopy, greater pectoral
muscles were thinly sliced and placed in 2.5% glutaraldehyde at
4uC overnight. The tissue was rinsed twice with 0.1 M phosphate-
buffered saline (PBS) and post-fixed with 1% osmium tetroxide on
ice for 1 hour. Then, the tissue underwent a graded ethanol
dehydration series and was infiltrated using a mixture of one-half
propylene oxide and one-half resin for one hour. One hour later,
the tissue was embedded in resin for four hours and then
polymerized at 37uC for 10 hours followed by 60uC for 24 hours.
One hundred nanometer sections were cut and stained with 4%
uranyl acetate for 20 minutes and 0.5% lead citrate for five
minutes. The sections were observed with a JEM-1400 transmis-
sion electron microscope (JEOL, Tokyo, Japan) operated at
80 kV. Electron micrographs were taken with a Gatan multiscan
camera with Gatan digital micrograph software version 1.81.78
(Gatan, Pleasanton, CA, USA).
Secondary transmission of amyloid fibrils isolated from
muscle
Amyloid fibril fractions were isolated from the muscles of
AApoAII-deposited Apoa2
cTg
+/2 mice or R1.P1-Apoa2
c mice
without AApoAII-deposition. 100 ml (2.5 mg/ml) of the amyloid
fibril fractions were injected into two-month-old female R1.P1-
Apoa2
c mice, and after two months, the mice were sacrificed and
the intensity of AApoAII amyloid deposition was determined semi-
quantitatively using the amyloid index (AI). The AI was
determined by taking the mean value of the scores of amyloid
deposition (graded from 0 to 4) in the seven major organs (liver,
spleen, tongue, heart, intestine, stomach, and skin) stained with
Congo Red as described previously [10].
Amyloid fibril fractions were denatured in a solution of 6 mol/L
guanidine hydrochloride, 0.1 mol/L Tris-HCl (pH 10.0), and
50 mmol/L dithiothreitol (1.0 mg/mL) for 24 hours at room
temperature with gentle stirring. Denatured amyloid fractions
were dialyzed quickly against 10 mmol/L NH4HCO3 solution.
The solution was injected into two-month-old female R1.P1-
Apoa2
c mice that were treated as described above.
Statistical analysis
We used the StatView software package (Abacus Concepts,
Berkeley, CA, USA) to perform statistical analyses. Significant
differences in the value of AI among the various groups of mice
were examined using the Mann-Whitney U-test.
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